Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

87
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
87
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

78
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
78
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

107
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
107
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

62
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
62
Dialysis01:27

Dialysis

505
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
505
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

52
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
52

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same authorSame journal

Disparities in Telemedicine Utilization Among Kidney Transplant Candidates and Recipients.

Kidney360·2026
Same author

Assessment of Medicare Advantage Stars Measures: Impact on Kidney Care Quality and Future Opportunities.

Journal of the American Society of Nephrology : JASN·2026
Same author

Donor Urinary Biomarkers and the Prediction of Deceased Donor Allograft Function.

Journal of the American Society of Nephrology : JASN·2026
Same author

Evaluating Barriers to Kidney Transplantation in the United States.

Journal of the American Society of Nephrology : JASN·2026
Same author

Largest Year-on-Year Decline in Deceased Donation in United States History.

Clinical transplantation·2026
Same author

Newly Designed Expedited Allocation Pathways Cannot Be Expected to Rely on Data That Does Not Currently Exist.

Kidney360·2026

相关实验视频

Updated: Sep 19, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

872

在ESKD的金融毒性.

Lindsey M Maclay1,2, Kyle Woodward1,2, Natalie Strohmayer1,2

  • 1Department of Medicine, Division of Nephrology, Columbia University Vagelos College of Physicians & Surgeons, New York, NY, USA.

Kidney360
|June 5, 2025
PubMed
概括
此摘要是机器生成的。

患有功能衰竭的患者面临着严重的财务毒性,71%的患者经历了这种情况. 许多人报告说,就业和收入减少,尤其是透析患者,强调治疗对财务福祉的影响.

更多相关视频

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.5K
Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
09:00

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology

Published on: March 27, 2018

7.5K

相关实验视频

Last Updated: Sep 19, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

872
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.5K
Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
09:00

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology

Published on: March 27, 2018

7.5K

科学领域:

  • 腎臟病學 (nephrology) 是一種醫學.
  • 卫生经济学 卫生经济学
  • 公共卫生 公共卫生

背景情况:

  • 治疗功能衰竭需要大量的时间和精力.
  • 这些治疗可以干扰就业能力,并产生间接成本.
  • 对于患有功能衰竭的患者来说,金融毒性是一个重大问题.

研究的目的:

  • 描述功能衰竭患者中金融毒性的流行情况.
  • 识别与金融毒性相关的风险因素.
  • 探索替代疗法模式与财务负担之间的关系.

主要方法:

  • 对112名功能衰竭患者进行的横截面调查研究.
  • 使用验证的成本工具 (CoST) 和自我报告的财务变化评估财务毒性.
  • 按脏替代疗法 (透析,移植) 方式对财务毒性的比较.

主要成果:

  • 71%的参与者至少经历了轻微的金融毒性 (中位数为17).
  • 金融毒性在非白人患者和接受透析的患者中更为普遍.
  • 超过60%的人报告工作减少,57%的人报告收入减少,特别是在透析患者中.

结论:

  • 患有功能衰竭的成年人经历了相当大的财务毒性.
  • 就业和收入的负面变化很常见,与功能衰竭有关.
  • 治疗方式,如透析,显著影响患者面临的财务负担.